← Companies|Enochian Bio
EN

Enochian Bio

ENOB·NASDAQLos Angeles CAFounded 201720 employees
Micro CapbiotechPublicInfectious DiseaseOncology
Platform: HIV/HBV Gene
Market Cap
$0.01B
All Drugs
2
Clinical Trials
5
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (ENOB)
Loading ENOB stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
LisozanubrutinibENO-5223Approved3Bispecific AbEGFRCAR-T BCMAFSGSCholangiocarcinoma
IvozasiranENO-3017Preclinical2mAbTIGITHPK1iETUC
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)
2025-03-02
Lisozanubrutinib Ph3 Readout
Endometrial Ca
Past
2026-01-27
Lisozanubrutinib Ph3 Readout
FSGS
Past
2028-07-16
Ivozasiran Interim
UC
Interim
2029-06-20
Lisozanubrutinib Ph3 Readout
FSGS
Ph3 Readout